MaRS Innovation and others commit over $1 Million to rapid molecular diagnostic technology
Staff
General DPNMaRS Innovation announced a $500,000 investment in the Toronto company, Xagenic Inc. When combined with funds from other investors and lenders, the new working capital provided to Xagenic totals $1.04 million.
Advertisement
Stories continue below
